您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2017, Vol. 55 ›› Issue (7): 55-60.doi: 10.6040/j.issn.1671-7554.0.2016.1098

• 临床医学 • 上一篇    下一篇

放射性125I粒子植入与外放疗治疗颈椎转移瘤剂量学对比分析

曹倩倩1,姜玉华1,李玉亮2,杨瑞杰3,刘路3,张喜乐3,王俊杰3   

  1. 1.山东大学第二医院肿瘤防治中心, 山东 济南 250033;2.山东大学第二医院介入医学科, 山东 济南 250033;3.北京大学第三医院放疗科, 北京 100191
  • 收稿日期:2016-09-02 出版日期:2017-07-10 发布日期:2017-07-10
  • 通讯作者: 王俊杰. E-mail:junjiewang_edu@sina.cn E-mail:junjiewang_edu@sina.cn
  • 基金资助:
    山东大学第二医院青年基金(Y2015010009)

A dosimetric analysis of cervical metastases between radioactive 125I seeds implantation and external beam radiation therapy

CAO Qianqian1, JIANG Yuhua1, LI Yuliang2, YANG Ruijie3, LIU Lu3, ZHANG Xile3, WANG Junjie3   

  1. 1. Cancer Center, Second Hospital of Shandong University, Jinan 250033, China;
    2. Interventional Medical Center, Second Hospital of Shandong University, Jinan 250033;
    3. Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China
  • Received:2016-09-02 Online:2017-07-10 Published:2017-07-10

PDF (PC)

345

摘要： 目的 对比放射性125I粒子植入与不同外放疗技术治疗颈椎转移瘤的靶区及危及器官剂量分布,为临床治疗方式选择提供依据。 方法 随机选取10例颈椎转移瘤患者,三维适形放射治疗(3D-CRT)计划为单前野加双侧斜后野,调强适形放射治疗(IMRT)为5野等分,选用2弧容积旋转调强放疗(VMAT)。将Oncentra治疗计划系统中的图像传输到粒子计划系统,制定近距离放疗(LDR)术前模拟计划。 结果 脊髓剂量相同时,LDR的D90和D95生物等效剂量(BED)分别为(184.15±25.84 )Gy、(161.45±26.35 )Gy。VMAT、IMRT、3D-CRT对应的靶区 D95 BED 2 Gy/f时分别为:(120.52±10.66)Gy、(119.19±10.91)Gy、(96.24±28.65)Gy;3 Gy/f时分别为:(122.19±7.54)Gy、(122.37±8.19)Gy、(95.94±24.70)Gy。靶区各参数与LDR相比,均服从正态分布,配对t检验差异具有统计学意义(P=0.00)。VMAT、IMRT与LDR比较,黏膜V5差异无统计学意义(P=0.16,0.34),只有3D-CRT高于LDR(P=0.00)。黏膜V30、Dmean LDR均低于3种外放疗技术(P=0.00)。其余甲状腺、腮腺、下颌骨各参数,LDR最低,差异具有统计学意义(P=0.00)。 结论 3D-CRT、IMRT、VMAT单次2 Gy及3 Gy分割方案与LDR相比,脊髓剂量相同时,LDR的靶区剂量更高,同时有效地保护周围危及器官。对于放疗后复发的颈椎椎体转移瘤,LDR具有剂量学优势。

关键词: 颈椎肿瘤, 外放疗, 125I粒子, 剂量学, 近距离治疗

Abstract: Objective To compare the gross tumor volume(GTV)and dose distributions for organs at risk(OAR)between external beam radiation therapy(EBRT)and low-dose rate(LDR)brachytherapy in the treatment of cervical vertebral metastases, in order to provide the basis for clinical treatment. Methods A total of 10 patients were randomly selected. Three-dimensional conformal radiotherapy(3D-CRT)planning was a single forth one with two oblique radiation fields. Intensity modulated radiotherapy(IMRT)planning included five equal radiation fields, and 2-arc volumetric-modulated arc radiotherapy(VMAT)was adopted. The images from Oncentra treatment planning system(TPS)were delivered to Prowess TPS to formulate LDR brachytherapy pre-operative simulation plan. Results For the same dose of spinal cord, the biologically effective dose(BED)of D90 and D95 of LDR were(184.15±25.84)Gy and(161.45±26.35)Gy. When the fraction scheme was 2 Gy/f, the D95 BED of VMAT, IMRT and 3D-CRT were(120.52±10.66)Gy,(119.19±10.91)Gy and(96.24±28.65)Gy. When the fraction scheme was 3 Gy/f, the 山 东 大 学 学 报 (医 学 版)55卷7期 -曹倩倩,等.放射性125I粒子植入与外放疗治疗颈椎转移瘤剂量学对比分析 \=-D95 BED 3 Gy/f of VMAT, IMRT and 3D-CRT were(122.19±7.54)Gy,(122.37±8.19)Gy and(95.94±24.70)Gy. All parameters complied with the normal distribution, P=0.00 after paired t test. There was no statistical difference in V5 of the mucosa among VMAT, IMRT and LDR(P=0.16, 0.34), and V5 of the mucosa of 3D-CRT was higher than that in LDR(P=0.00). The V30 and Dmean of LDR were less than those of 3D-CRT, VMAT and IMRT, statistically(P=0.00). Other parameters of the thyroid gland, parotid gland and mandible were significantly different between LDR and 3D-CRT, VMAT and IMRT(P=0.00). Conclusion When the fraction schemes were 2 Gy/f and 3 Gy/f, 3D-CRT, IMRT and VMAT had lower GTV doses than LDR, which could protect the OARs at the same time. Therefore, as to the cervical vertebral metastases after EBRT, LDR is a good choice for salvage treatment.

Key words: Cervical tumor, External Beam Radiation Therapy, Dosimetry, Brachytherapy, 125I seeds

中图分类号: 

  • R738.1
[1] Mesfin A, Buchowski JM, Gokaslan ZL, et al. Management of metastatic cervical spine tumors[J]. J Am Acad Orthop Surg, 2015, 23(1): 38-46.
[2] Chow E, Zeng L, Salvo N, et al. Update on the systematic review of palliative radiotherapy trials for bone metastases[J]. Clin Oncol-Uk, 2012, 24(2): 112-124.
[3] Rogers CL, Theodore N, Dickman CA, et al. Surgery and permanent 125I seed paraspinal brachytherapy for malignant tumors with spinal cord compression[J]. Int J Radiat Oncol Biol Phys, 2002, 54(2): 505-513.
[4] Wang J, Yuan H, Ma Q, et al. Interstitial 125I seeds implantation to treat spinal metastatic and primary paraspinal malignancies[J]. Med Oncol, 2010, 27(2): 319-326.
[5] Cao QQ, Wang H, Meng N, et al. CT-guidance interstitial 125Iodine seed brachytherapy as a salvage therapy for recurrent spinal primary tumors[J]. Radiat Oncol, 2014, 9: 301. doi: 10.1186/s13014-014-0301-8.
[6] 柳晨, 王俊杰, 孟娜, 等. CT引导下放射性125I粒子置入治疗脊柱转移性肿瘤的价值[J]. 中国脊柱脊髓杂志, 2011, 21(3): 226-229. LIU Chen, WANG Junjie, MENG Na, et al. CT-guide interstitial iodine-125 seed implantation for metastatic spine tumor[J]. Chinese Journal of Spine and Spinal Cord, 2011, 21(3): 226-229.
[7] Huisman M, van der Velden JM, van Vulpen M, et al. Spinal instability as defined by the spinal instability neoplastic score is associated with radiotherapy failure in metastatic spinal disease[J]. Spine J, 2014, 14(12): 2835-2840.
[8] Hodapp N. The ICRU report 83: prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy(IMRT)[J]. Strahlenther Onkol, 2012 188(1):97-99.
[9] Mesfin A, Buchowski JM, Gokaslan ZL, et al. Management of metastatic cervical spine tumors[J]. J Am Acad Orthop Surg, 2015, 23(1): 38-46.
[10] Ju DG, Zadnik PL, Groves ML, et al. Factors associated with improved outcomes following decompressive surgery for prostate cancer metastatic to the spine[J]. Neurosurgery, 2013, 73(4): 657-666.
[11] Ramieri A, Domenicucci M, Ciappetta P, et al. Spine surgery in neurological lesions of the cervicothoracic junction: multicentric experience on 33 consecutive cases[J]. Eur Spine J, 2011, 20(1): 13-19.
[12] Dalbayrak S, Yaman O, Yilmaz M, et al. Results of the transsternal approach to cervicothoracic junction lesions[J]. Turk Neurosurg, 2014, 24(5): 720-725.
[13] 张喜乐, 杨瑞杰, 孟娜, 等. 一种新的混合旋转调强放射治疗技术治疗颈椎原发恶性肿瘤剂量学研究[J]. 现代肿瘤学杂志, 2014, 22(12): 2964-2969. ZHANG Xile, YANG Ruijie, MENG Na, et al. Dosimetric study of a novel hybrid volumetric modulated arc therapy technique for primary cervical spine malignant tumors[J]. Modern Oncology, 2014, 22(12): 2964-2969.
[14] Georg D, Hopfgartner J, Gòra J, et al. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy[J]. Int J Radiat Oncol Biol Phys, 2014, 88(3): 715-722.
[15] Holloway RP, Dale RG. Theoretical implications of incorporating relative biological effectiveness into radiobiological equivalence relationships[J]. Br J Radiol, 2013, 86(1022): 20120417. doi: 10.1259/bjr.20120417..
[16] Skowronek J, Malicki J, Piotrowski T. Values of biologically equivalent doses in healthy tissues comparison of PDR and HDR brachytherapy techniques[J]. Brachytherapy, 2010, 9(2): 165-170.
[17] Gay HA, Jin JY, Chang AJ, et al. Utility of normal tissue-to-tumor α/β ration when evaluating isodses of isoeffective radiation therapy treatment plans[J]. Int J Radiat Oncol Biol Phys, 2013, 85(1): 81-87.
[18] Brown JM, Carlson DJ, Brenner DJ. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?[J]. Int J Radiat Oncol Biol Phys, 2014, 88(2): 254-262.
[19] Kirkpatrick JP, van der Kogel AJ, Schultheiss TE. Radiation dose-volume effects in the spinal cord[J]. Int J Radiat Oncol Biol Phys, 2010, 76(3): 42-49.
[20] 张颖, 林琦, 袁苑, 等. 3D打印个体化模板联合CT引导125I粒子植入治疗胸壁转移瘤1例[J]. 山东大学学报(医学版), 2016, 54(4): 94-96.
[21] Yao L, Jiang Y, Jiang P, et al. CT-guided perment 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy[J]. Brachytherapy, 2015, 14(5): 662-669.
[1] 林琦,张颖,袁苑,戴建建,徐瑞彩,杨琦,耿宝成,韩明勇. 肾上腺转移瘤放射性125I粒子植入治疗后胃穿孔1例[J]. 山东大学学报（医学版）, 2017, 55(7): 124-129.
[2] 柴树德. 我国放射性粒子植入治疗支气管肺癌现状与技术创新[J]. 山东大学学报（医学版）, 2017, 55(2): 4-7.
[3] 霍彬,王磊,王海涛,霍小东,曹强,王丽丽,臧立,王金焕,郑广钧, 柴树德. 模板联合肋骨钻孔技术辅助放射性粒子植入治疗肺癌的可行性[J]. 山东大学学报（医学版）, 2017, 55(2): 26-31.
[4] 戴建建,袁冰,张颖,林琦,袁苑,韩明勇. CT引导下125I粒子植入治疗Ⅲ期非小细胞肺癌疗效与并发症的临床观察[J]. 山东大学学报（医学版）, 2017, 55(2): 32-37.
[5] 林琦,张颖,戴建建,徐瑞彩,杨琦,耿宝成,韩明勇. CT引导放射性125I粒子植入治疗23例浅表淋巴结转移瘤[J]. 山东大学学报（医学版）, 2017, 55(2): 38-44.
[6] 许玉军,柳明,何祥萌,李成利. 1.0T开放型磁共振引导经皮穿刺125I放射性粒子植入治疗晚期胰腺癌[J]. 山东大学学报（医学版）, 2017, 55(2): 21-25.
[7] 张颖,林琦,袁苑,戴建建,耿宝成,徐瑞彩,刘亚坤,韩明勇. 3D打印个体化模板联合CT引导125I粒子植入治疗肿瘤术前术后剂量学比较[J]. 山东大学学报（医学版）, 2017, 55(2): 45-49.
[8] 李扬,何闯,陈玉潇,杨丽,李良山,李廷源,黄学全. 放射性125I粒子植入近距离治疗长骨转移瘤的临床疗效[J]. 山东大学学报（医学版）, 2017, 55(2): 50-54.
[9] 袁苑,张颖,林琦,戴建建,李冉冉,徐瑞彩,杨琦,耿宝成,韩猛,韩明勇. 125I粒子植入术后应用透明质酸钠凝胶皮下注射保护皮肤1例[J]. 山东大学学报（医学版）, 2017, 55(11): 89-92.
[10] 王丽丽,霍彬,王磊,汪浩,侯定坤,霍小东,王金焕,臧立,曹强,柴树德,王海涛. 亚肺叶切除联合125I粒子植入治疗早期肺癌有效性的Meta分析与系统评价[J]. 山东大学学报（医学版）, 2017, 55(10): 76-83.
[11] 张颖,林琦,袁苑,戴建建,耿宝成,徐瑞彩,刘亚坤,韩明勇. 3D打印个体化模板联合CT引导125I粒子植入治疗胸壁转移瘤1例[J]. 山东大学学报（医学版）, 2016, 54(4): 94-96.
[12] 房菲菲,张颖,林琦,袁苑,戴建建,徐瑞彩,耿宝成,韩明勇. CT引导放射性125I粒子植入治疗转移性肝癌的临床疗效[J]. 山东大学学报（医学版）, 2016, 54(12): 53-57.
[13] 张颖,林琦,袁苑,戴建建,耿宝成,徐瑞彩,刘亚坤,韩明勇. 3D打印个体化模板联合CT引导125I粒子植入治疗恶性肿瘤质量评价[J]. 山东大学学报（医学版）, 2016, 54(11): 44-50.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发